STAKEHOLDER SEMINAR ON PHARMACEUTICALS IN INDIA THE NEXT LEAP
28 April 2017
Jacaranda Hall, India Habitat Centre, New Delhi
1530 hours Registration & High Tea
INAUGURAL SESSION
1600 1605 Welcome remarks
Mr Anwarul Hoda, Chair Professor, Trade Policy & WTO Research Programme, ICRIER; Former Deputy Director General, WTO; Former Member, Planning Commission, GOI
1605 1615 Inaugural address
Shri K L Sharma, Joint Secretary, Ministry of Health and Family Welfare, GOI
1615 1635 Special addresses
Dr G N Singh, Drugs Controller General of India, CDSCO, GOI
Dr Agnes Saint-Raymond, Head of International Affairs Division, EMA
1635 1645 Presidential address Shri Lov Verma, Former Secretary, Ministry of Health and Family Welfare, GOI
*** RELEASE OF ICRIER REPORTS ON CLINICAL TRIALS AND DRUG REGISTRATION ***
1645 1745 Panel discussion The next leap for Indias pharmaceutical sector: Opportunities and challenges
Chair Dr G N Singh, Drugs Controller General of India, CDSCO, GOI
Panelists
Dr Y K Gupta, Professor and Head, Department of Pharmacology, AIIMS, New Delhi
Dr Suneela Thatte, Co-Chair, Medical and Regulatory Work Group, OPPI, Mumbai
Mr Richard Kingham, Senior Counsel, Covington and Burling LLP, Washington DC
Ms Susan Winckler, President, Leavitt Partners, Washington DC
Mr Bejon Misra, Founder, Partnership for Safe Medicines India, New Delhi Q&A
1745 1800 Tea break
PRESENTATION AND DISCUSSION SESSION
1800 1805 Chair Dr S Eswara Reddy, Joint Drugs Controller of India, CDSCO, GOI
1805 1820 Presentation 1 Challenges and prospects for clinical trials in India: A regulatory perspective
Rahul Mongia and Seema Rao ICRIER Health Policy Initiative
1820 1845 Q&A
1845 1900 Presentation 2 International cooperation for registration of medicines: Opportunities for India
Vasudha Wattal, Pallavi Joshi and Aashna Arora ICRIER Health Policy Initiative
1900 1925 Q&A
1925 1930 Vote of thanks
Dr Ali Mehdi, Project Leader, ICRIER Health Policy Initiative